☀ Trending Among Corona Carnage ☀ List of Best Performing Corona Vaccine Stocks, Tech Penny Stocks, Healthcare Stocks, and Artificial Intelligence Stocks. Biotech, or biotechnology, is defined as the exploitation and use of biological processes for industrial, commercial and other requirements, especially the genetic manipulation of microorganisms for the generation, production and development of medicinal elements like antibiotics and hormones which can be used for therapeutic use. It is the technology that uses biological systems, living organisms or their parts to build and develop different products. The specialized sub-sector falls within the larger health care sector and involves activities like drug development, research, manufacturing and marketing in the field of biotech. Among the big basket of Biotech stocks, which ones generated the top returns this year? Which of those figured among the winners in the long list of Biotech stocks? This article provides a list of Biotech stocks which have generated the highest returns in the year 2021 so far. till date of writing. The list is prepared based on the percentage returns generated by the individual Biotech stocks between the end of the previous year and Jul 12, 2021, and the top 10 return generating Biotech stocks are listed below.
Best Performing Stock Screener:
This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.
The following list presents stocks of the companies which belong to the broader Biotech sector or the stock market index, their corresponding prices as of given date, and the percentage gains realized: 1) KemPharm, Inc. (KMPH)
Here's a look at the basic details and how the above mentioned stocks fared during the period:
KemPharm
KemPharm, Inc., incorporated on May 28, 2014, is a clinical-stage specialty pharmaceutical company. The Company is engaged in the discovery and development of prodrugs. The Company uses its Ligand Activated ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of KemPharm. The Iowa, IA-headquartered company KemPharm, Inc. (KMPH) is ranked number one among the best performing stocks of Biotech of 2021. The Healthcare sector business falls under the Major Pharmaceuticals industrial sub-sector. Since the start of the year 2021, the stock price of KemPharm has changed by 1736.11 percent, which is calculated based on the previous year's closing price of $0.72 per share and year-to-date closing price of $13.22 per share as of writing. The market value of the company as indicated by its market-cap changed from $3.27 million to $448.08 million during the same period. Along with Biotech, the company is also in the business of Health Care, Major Pharmaceuticals, Biotechnology, Healthcare, Wilshire 5000, among other usual products and services. KemPharm continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
Cassava Sciences, Inc.
Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Cassava Sciences, Inc.. During the given months of the year 2021, Cassava Sciences, Inc. (SAVA) was successful in generating YTD returns of 1356.3 percentage which helped it gain the number two spot in the list of the top performing stocks which generated maximum returns during year 2021 till date. As of December of the previous year, the stock of the Austin, United States-based Cassava Sciences, Inc. closed at a price of $6.82 per share, while it traded at a price of $99.32 per share as of Jul 12, 2021. The company's market cap changed from $0 million to $3.97 billion during the same period YTD. The company is classified under the Healthcare industry sector and further specialized as a Major Pharmaceuticals sector business.
Onconova Therapeutics
Onconova Therapeutics, Inc., incorporated on December 22, 1998, is a clinical-stage biopharmaceutical company. The Company operates through the identification and development of oncology therapeutics segment. It is focused on discovering ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Onconova Therapeutics. Rank number three in the coveted list is held by Onconova Therapeutics, Inc. (ONTX) for being among the top performing stocks of 2021. Headquartered in Pennsylvania, PA, the Healthcare sector company is categorized under the industrial sub-sector of Major Pharmaceuticals. Since the start of the year 2021, stock of Onconova Therapeutics has so far gained 1183.81 percentage, based on the previous year's closing price of $0.47 per share and year-to-date price of $5.98 per share. During the same period, the market capitalization of the company changed from $86.15 million to $94.37 million. The stock of Onconova Therapeutics continues to be a major constituent of many leading stock indexes which include Wilshire 5000 index, and several other broader level multi-cap market indicators.
Novan
Novan, Inc. is a late-stage pharmaceutical company. The Company is engaged in the development and commercialization of therapies using its nitric oxide platform. The Company develops product candidates using its ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Novan. At number four in the list of top stocks stands Novan, Inc. (NOVN), which saw a change in its stock price from the level of $0.81 apiece during previous year December end to the price of $9.07 per share as of Jul 12, 2021. It translates to a change of 1015.62 percentage. The North Carolina, NC-headquartered Healthcare sector company also saw its market value change from $115.05 million to $170.58 million.
Acorda Therapeutics
Acorda Therapeutics, Inc., incorporated on March 17, 1995, is a biopharmaceutical company. The Company focuses on developing therapies that restore function and improve the lives of people with neurological disorders. ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Acorda Therapeutics. The New York, NY-based Healthcare sector company Acorda Therapeutics, Inc. (ACOR) holds the number five spot among the best performing stocks of the Biotech sector. Classified as the Biotech Biological Products business, the stock price of Acorda Therapeutics ended the previous year at a price of $0.69 per share while it reached the level of $4.22 apiece as of Jul 12, 2021 translating to a percentage change in stock price of 511.51%. As of writing, the company's market-cap value stands at $46.95 million. Few leading stock market index includes Acorda Therapeutics in their constituent list. They include Wilshire 5000 index, and a few other larger indexes which are part of the stock market.
Entera Bio
Entera Bio Ltd., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of orally delivered large molecule therapeutics for unmet medical needs. The company's lead product ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Entera Bio. Entera Bio Ltd. (ENTX) has moved by 432.41 percentage over the given period of 2021-YTD, helping it gain a place at number six among the top performing stocks. The Healthcare sector company managed to achieve the feat as its stock price changed from $1.08 apiece to the price of $5.75 per share between the end of December of the previous year and Jul 12, 2021. The smart run of the Jerusalem, -based Healthcare sector company lead to a handsome gain in its marketcap which changed from $19.83 million to $136.72 million over the same duration.
PDS Biotechnology Corporation
PDS Biotechnology Corporation, a clinical-stage biopharmaceutical company, focuses on developing multifunctional cancer immunotherapies. Its lead product ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of PDS Biotechnology Corporation. The number seven spot in the list of top performing stocks of the Biotech sector is taken by PDS Biotechnology Corporation (PDSB). The company's stock price changed from $2.14 per share at the end of December of the previous year to the price of $10.02 per share as of writing. Overall, the stock managed to realized price change of 368.22 percent during the given time period. The corresponding change in the market capitalization value of the Florham Park, United States-based Healthcare sector company was from $0 million to $284.23 million. Being ranked in the top 10 best performing stocks of the Biotech sector, the company also succeeded in outperforming the returns generated by some of the popular stock market indexes.
Anavex Life Sciences
Anavex Life Sciences Corp., incorporated on January 23, 2004, is a clinical-stage biopharmaceutical company. The Company is engaged in the development of differentiated therapeutics for the treatment of neurodegenerative and ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Anavex Life Sciences. Anavex Life Sciences (AVXL) generated percentage returns of 355.56 percent during the 2021 year-to-date. Its returns are based on the share price which moved from $5.4 per share from the previous year-end to the price of $24.6 per share as of Jul 12, 2021. The company's value, as indicated by the market-cap figure, changed from $361.6 million to $1.78 billion during the same period. The company is categorized as a Healthcare speciality business with further classification in the Biotech-Commercial Physical Biological Research sub-category. Based in New York, NY, the YTD performance of the Biotech sector also fared better than that of the returns generated by some of the closley tracked stock market indexes. The company is a part of Wilshire 5000 index, and a few other wider multi-cap stock market indexes.
Prothena
Prothena Corporation Public Limited Company, incorporated on September 26, 2012, is a global biotechnology company. The Company is focused on the discovery, development and commercialization of immunotherapies for the treatment ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Prothena. The California, CA-based Prothena Corporation plc (PRTA) belongs to the Healthcare sector and is categorized as a Major Pharmaceuticals company. The stock of Prothena ended the previous year at a price of $12.01 per share. As of Jul 12, 2021, the stock price has reached $54.39 apiece, which indicates a change of 352.87 percent making the company rank among the top performing stocks of the Biotech for the year 2021 till date. At the end of the last year, company's market capitalization stood at $479.46 million. It has now changed to $2.4 billion as of writing. Prothena continues to be a leading constituent of many major stock market indexes like Wilshire 5000 index, and several other broader level multi-cap market indicators.
Pandion Therapeutics
Pandion Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on developing various therapeutics to address the unmet needs of patients ... see Detailed Company Profile, full Dividend History, and List of ETFs holding the stock of Pandion Therapeutics. Based on the market-cap change from $438.37 million to $1.77 billion during the given months of the year 2021 and the share price change from $14.85 per share to a price of $60.05 per share as of Jul 12, 2021, Pandion Therapeutics, Inc. (PAND) was successful in generating YTD returns of 304.38 percentage. Standing at the number ten rank in the top performing list of Biotech stocks, the Watertown, Massachusetts-based Pandion Therapeutics is categorized as the Biotechnology sub-sector business which falls under the larger Healthcare sector.This page is updated every week/month. Bookmark this site to track the best performing stocks regularly.